CD13 expression on CD5-negative and CD5-positive B-cells in patients with chronic lymphocyte leukemia (B-CLL).

被引：0
|
作者：
Kampalath, B [1 ]
Barcos, M [1 ]
Stewart, C [1 ]
机构：
[1] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：133A / 133A
页数：1
相关论文
共 50 条
  • [1] THE IMPORTANCE OF CD5-POSITIVE B-CELLS
    YOUINOU, P
    MACKENZIE, L
    BROKER, BM
    ISENBERG, DI
    LYDYARD, PM
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (04) : 502 - 502
  • [2] Rituximab for CD5-positive & CD5-negative diffuse large B-cell lymphoma
    Hyo, R.
    Tomita, N.
    Takeuchi, K.
    Aoshima, T.
    Fujita, A.
    Kuwabara, H.
    Hashimoto, C.
    Takemura, S.
    Taguchi, J.
    Sakai, R.
    Fujita, H.
    Fujisawa, S.
    Ogawa, K.
    Motomura, S.
    Suzuki, R.
    Ishigatsubo, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 147 - 147
  • [3] Cd5-negative clonal B lymphocytosis: Are they CLL?
    Simeone, L.
    Chiurazzi, F.
    Petruzziello, F.
    Scalia, G.
    Gorrese, M.
    Abate, G.
    Raia, M.
    Romano, C.
    Sellitto, A.
    De Fanis, U.
    Del Vecchio, L.
    Lucivero, G.
    Rotoli, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 114 - 114
  • [4] CD5-POSITIVE B-CELLS IN RHEUMATOID-ARTHRITIS AND CHRONIC LYMPHOCYTIC-LEUKEMIA
    LYDYARD, PM
    YOUINOU, PY
    COOKE, A
    IMMUNOLOGY TODAY, 1987, 8 (02): : 37 - 39
  • [5] CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40
    Gagro, A
    Mccloskey, N
    Challa, A
    Holder, M
    Grafton, G
    Pound, JD
    Gordon, J
    IMMUNOLOGY, 2000, 101 (02) : 201 - 209
  • [6] Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: Comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia
    Finn, WG
    Singleton, TP
    Schnitzer, B
    Ross, CW
    Stoolman, LM
    HUMAN PATHOLOGY, 2001, 32 (01) : 66 - 73
  • [7] The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma
    Hyo, Rie
    Tomita, Naoto
    Takeuchi, Kengo
    Aoshima, Tomohiro
    Fujita, Atsuko
    Kuwabara, Hideyuki
    Hashimoto, Chizuko
    Takemura, Sachiya
    Taguchi, Jun
    Sakai, Rika
    Fujita, Hiroyuki
    Fujisawa, Shin
    Ogawa, Koji
    Motomura, Shigeki
    Suzuki, Ritsuro
    Ishigatsubo, Yoshiaki
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (01) : 27 - 32
  • [8] CD5 POSITIVE AND NEGATIVE B-CLL - EVIDENCE SUPPORTING PHENOTYPIC HETEROGENEITY IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    FAGUET, GB
    MARTI, GE
    AGEE, JF
    BERTIN, P
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 470 - 474
  • [9] CD5-POSITIVE AND CD5-NEGATIVE RHEUMATOID FACTOR-SECRETING B-CELLS IN IGA NEPHROPATHY, RHEUMATOID-ARTHRITIS AND GRAVES-DISEASE
    JONES, BM
    CHENG, IKP
    WONG, RWS
    KUNG, AWC
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1993, 38 (06) : 575 - 580
  • [10] CD5-positive versus CD5-negative diffuse large B-cell lymphoma treated with immunochemotherapy: Is there a difference?
    Popovic, L.
    Markovic, O.
    Jovanovic, D.
    Marisavljevic, D.
    Petrovic, D.
    Mihaljevic, B.
    Popovic, M.
    Matkovic, T.
    Matovina-Brko, G.
    Zivkovic, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S845 - S846
12345